MODERNA INC. DL-,0001/ US60770K1079 /
24/05/2024 08:09:26 | Chg. 0.00 | Volume | Bid09:32:51 | Ask09:32:51 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
151.40EUR | 0.00% | 0 Turnover: 0.00 |
150.50Bid Size: 150 | 150.84Ask Size: 150 | 58.12 bill.EUR | - | - |
GlobeNewswire
22/05
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
12/05
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
08/05
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
01/05
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
01/05
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
04/04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
04/03
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024